Category: Life Sciences
Global Life Sciences
-
Medical Specialty Bags
... at a CAGR of 3.7% over the analysis period 2024-2030. Ostomy Bags, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$2.7 Billion by the end of ... Read More
-
Orthopedic Devices
... CAGR of 6.5% over the analysis period 2024-2030. Joint Reconstruction Devices, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$44.6 Billion by the end of the ... Read More
-
Orthopedic Orthotics
... CAGR of 6.5% over the analysis period 2024-2030. Lower-Limb Orthotics, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$2.2 Billion by the end of the analysis ... Read More
-
Specialty Medical Chairs
... at a CAGR of 4.6% over the analysis period 2024-2030. Rehabilitation Chairs, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$1.7 Billion by the end of ... Read More
-
Intravenous Equipment
... CAGR of 3.4% over the analysis period 2024-2030. IV Catheters, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$4.8 Billion by the end of the analysis ... Read More
-
Ophthalmic Instrumentation
... CAGR of 4.6% over the analysis period 2024-2030. Ophthalmic Disposables, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$3.6 Billion by the end of the analysis ... Read More
-
Respiratory Care Devices
... at a CAGR of 5.8% over the analysis period 2024-2030. Therapeutic Devices, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$15.7 Billion by the end of ... Read More
-
Immunoassay Systems
... CAGR of 3.6% over the analysis period 2024-2030. Immunoassay Reagents & Kits, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$19.4 Billion by the end of ... Read More
-
Stem Cells
... CAGR of 7.4% over the analysis period 2024-2030. Adult Stem Cells, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$17.8 Billion by the end of the ... Read More
-
Anti-Adhesion Products
... CAGR of 4.3% over the analysis period 2024-2030. Synthetic Anti-Adhesion Products, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$499.7 Million by the end of the ... Read More
-
Organ Preservation Solutions
... at a CAGR of 4.9% over the analysis period 2024-2030. Static Cold Storage Technique, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$161.8 Million by the ... Read More
-
Ophthalmology Picture Archiving and Communication Systems
... reach US$211.3 Million by 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Integrated PACS, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach ... Read More
-
DPP-IV Inhibitors
... CAGR of 1.7% over the analysis period 2024-2030. The U.S. Market is Estimated at US$3.5 Billion While China is Forecast to Grow at 1.7% CAGR The DPP-IV Inhibitors market in the U.S. is estimated at ... Read More
-
Overactive Bladder (OAB) Therapeutics
... 2030, growing at a CAGR of 2.8% over the analysis period 2024-2030. Anticholinergics, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$614.7 Million by the end ... Read More
-
Next Generation Sequencers
... at a CAGR of 17.3% over the analysis period 2024-2030. Next Generation Sequencer Consumables, one of the segments analyzed in the report, is expected to record a 17.1% CAGR and reach US$26.6 Billion by the ... Read More
-
Artificial Implants
... CAGR of 5.5% over the analysis period 2024-2030. Cardiac Implants, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$52.0 Billion by the end of the analysis ... Read More
-
Ion Channel Modulators
... at a CAGR of 3.5% over the analysis period 2024-2030. Channel Blockers, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$12.4 Billion by the end of ... Read More
-
Animal Medication
... CAGR of 4.5% over the analysis period 2024-2030. Companion Animals Medication, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$20.7 Billion by the end of the ... Read More
-
Private Healthcare
... CAGR of 7.6% over the analysis period 2024-2030. The U.S. Market is Estimated at US$1.9 Trillion While China is Forecast to Grow at 11.0% CAGR The Private Healthcare market in the U.S. is estimated at ... Read More
-
Energy based Ablation Devices
... 2030, growing at a CAGR of 11.4% over the analysis period 2024-2030. Radiation Technology, one of the segments analyzed in the report, is expected to record a 10.5% CAGR and reach US$6.0 Billion by the ... Read More
-
Virtual Reality (VR)
... at a CAGR of 17.8% over the analysis period 2024-2030. VR Hardware, one of the segments analyzed in the report, is expected to record a 17.2% CAGR and reach US$82.9 Billion by the end of ... Read More
-
Deep Brain Stimulation Devices
... 2030, growing at a CAGR of 8.5% over the analysis period 2024-2030. Dual-Channel Devices, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$1.7 Billion by the ... Read More
-
Cardiovascular Catheters
... CAGR of 6.6% over the analysis period 2024-2030. Cardiovascular Therapeutic Catheters, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$25.4 Billion by the end of the ... Read More
-
Orthopedic Prosthetic Implants
... at a CAGR of 4.5% over the analysis period 2024-2030. Knee Prosthesis, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$14.9 Billion by the end of ... Read More
-
Audiological Devices
... CAGR of 6.7% over the analysis period 2024-2030. Hearing Aids, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$14.3 Billion by the end of the analysis ... Read More
Research Assistance
